S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners

Flame Acquisition (FLME) Social Media Sentiment and Mentions

$10.50
0.00 (0.00%)
(As of 11/27/2023 ET)
Compare
Today's Range
$10.50
$10.50
50-Day Range
$10.40
$10.60
52-Week Range
$9.91
$10.66
Volume
N/A
Average Volume
1,421 shs
Market Capitalization
$164.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Follows Over Time

Recieve Flame Acquisition News and Ratings via Email

Sign-up to receive the latest news and ratings for FLME and its competitors with MarketBeat's FREE daily newsletter.

FLME Social Media Mentions



Related Companies and Tools

This page (NYSE:FLME) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -